A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by persistent, chronic inflammation that damages organ tissue. One of the symptoms that is often found in SLE is cognitive dysfunction. Hydroxychloroquine is recommended for the treatment of all levels of SLE. Th...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Bantar Suntoko, Suharyo Hadisaputro, Handono Kalim, Suyanto Hadi, Ika Vemilia Warlisti
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Secretariat of The Indonesian Biomedical Journal 2023-08-01
Sraith:	Indonesian Biomedical Journal
Rochtain ar líne:	https://inabj.org/index.php/ibj/article/view/2504

Míreanna comhchosúla

Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction
de réir: Bantar Suntoko, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients
de réir: Perdana Aditya Rahman, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus
de réir: Liu Peng-Cheng, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Periodontal Tissue Condition on Systemic Lupus Erythematosus Patients: A Clinical Study
de réir: Nanda Rachmad Putra Gofur, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
de réir: Kisha D Piggott, et al.
Foilsithe / Cruthaithe: (2018-01-01)

New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
de réir: Chanchal Gera, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
de réir: Nanda R.P. Gofur, MS, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
de réir: Handono Kalim, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
de réir: Guillermo Ruiz-Irastorza, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Hydroxychloroquine in systemic lupus erythematosus and psychosis. A case report
de réir: M. Martínez Grimal, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
de réir: Z. Aouhab, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus
de réir: Michele Iudici, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Oral Hygiene and Dental Caries Status on Systemic Lupus Erythematosus Patients: A Cross-Sectional Study
de réir: Nanda Rachmad Putra Gofur, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
de réir: Alberto Floris, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Hydroxychloroquine lowers the risk for Diabetes Mellitus in patients with Systemic Lupus Erythematosus
de réir: Dennis Levinson, et al.
Foilsithe / Cruthaithe: (2022-10-01)

S15.1 Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
de réir: S Fasano, et al.
Foilsithe / Cruthaithe: (2022-10-01)

The phenotype of CD3–CD56bright and CD3–CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
de réir: Dwi Soelistyoningsih, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis
de réir: Dwi Soelistyoningsih, et al.
Foilsithe / Cruthaithe: (2024-09-01)

The Correlation between Serum Concentration of Vitamin D with Vitamin D Receptor Expression and Disease Activity in Indonesian Patients with Systemic Lupus Erythematosus: Preliminary Study
de réir: Kusworini Handono, et al.
Foilsithe / Cruthaithe: (2014-05-01)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
de réir: Ronald F van Vollenhoven, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
de réir: Tomoo Kise, et al.
Foilsithe / Cruthaithe: (2023-01-01)

An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
de réir: Atsushi Manabe, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
de réir: Peng-Cheng Liu, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
de réir: Noël Zahr, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
de réir: Bajwa A, et al.
Foilsithe / Cruthaithe: (2015-05-01)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
de réir: Wen-Ming Wang, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Extensive discoid lupus erythematosus in a HIV patient responding to hydroxychloroquine monotherapy
de réir: Pradeep Vittal Bhagwat, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment
de réir: Andrew R. Berneshawi, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
de réir: Peter Izmirly, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
de réir: John P. O’Laughlin, et al.
Foilsithe / Cruthaithe: (2016-01-01)

O9 Early pregnancy exposure to hydroxychloroquine and preterm delivery in systemic lupus erythematosus
de réir: Elisabet Svenungsson, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
de réir: Jae-Eun Lee, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
de réir: Alexander KC Leung, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Effect of vitamin D supplementation on disease activity (SLEDAI) and fatigue in Systemic Lupus Erythematosus patients with hipovitamin D: An Open Clinical Trial
de réir: Achmad Rifaâ€™i, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Efficacy of Hydroxychloroquine for Improving Pregnancy Outcomes in a Female with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
de réir: Yumika Takaki, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Author Correction: An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
de réir: Atsushi Manabe, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China
de réir: Xuan Huang, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus
de réir: Risa Wakiya, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
de réir: Juliana Cruz da Silva, et al.
Foilsithe / Cruthaithe: (2013-06-01)

Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine
de réir: Valentina Canti, et al.
Foilsithe / Cruthaithe: (2021-07-01)